American Journal of Cardiology
Volume 97, Issue 8 , Pages 1182-1187 , 15 April 2006

Comparison of Sirolimus Versus Paclitaxel Eluting Stents for Treatment of Coronary In-Stent Restenosis

  • Flavio Airoldi, MD

      Affiliations

    • San Raffaele Hospital IRCCS, Milan, Italy
  • ,
  • Carlo Briguori, MD, PhD

      Affiliations

    • San Raffaele Hospital IRCCS, Milan, Italy
  • ,
  • Ioannis Iakovou, MD

      Affiliations

    • EMO Centro Cuore, Columbus Hospital, Milan, Italy
  • ,
  • Goran Stankovic, MD

      Affiliations

    • Invasive Cardiology Unit, San Raffaele Institute, Milan, Italy
  • ,
  • Giuseppe Biondi-Zoccai, MD

      Affiliations

    • San Raffaele Hospital IRCCS, Milan, Italy
  • ,
  • Mauro Carlino, MD

      Affiliations

    • San Raffaele Hospital IRCCS, Milan, Italy
  • ,
  • Alaide Chieffo, MD

      Affiliations

    • San Raffaele Hospital IRCCS, Milan, Italy
  • ,
  • Matteo Montorfano, MD

      Affiliations

    • San Raffaele Hospital IRCCS, Milan, Italy
  • ,
  • John Cosgrave, MD

      Affiliations

    • EMO Centro Cuore, Columbus Hospital, Milan, Italy
  • ,
  • Iassen Michev, MD

      Affiliations

    • San Raffaele Hospital IRCCS, Milan, Italy
  • ,
  • Renata Rogacka, MD

      Affiliations

    • San Raffaele Hospital IRCCS, Milan, Italy
  • ,
  • Giuseppe Massimo Sangiorgi, MD

      Affiliations

    • EMO Centro Cuore, Columbus Hospital, Milan, Italy
  • ,
  • Antonio Colombo, MD

      Affiliations

    • San Raffaele Hospital IRCCS, Milan, Italy
    • EMO Centro Cuore, Columbus Hospital, Milan, Italy
    • Corresponding Author InformationCorresponding author: Tel: 39-02-481-2920; fax: 39-02-481-93433

Received 24 July 2005 ,Revised 8 November 2005 ,Accepted 8 November 2005.

References 

  1. Al Suwaidi J , Berger PB , Holmes DR . Coronary artery stents . JAMA . 2000;284:1828–1836
  2. Goldberg SL , Loussararian A , De Gregorio J , Di Mario C , Albiero R , Colombo A . Predictors of diffuse and aggressive intra-stent restenosis . J Am Coll Cardiol . 2001;37:1019–1025
  3. Eltchaninoff H , Koning R , Tron C , Gupta V , Cribier A . Balloon angioplasty for the treatment of coronary in-stent restenosis (immediate results and 6-month angiographic recurrent restenosis rate) . J Am Coll Cardiol . 1998;32:980–984
  4. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, et al. Angiographic patterns of in-stent restenosis (classification and implications for long-term outcome) . Circulation . 1999;100:1872–1878
  5. Mehran R, Mintz GS, Popma JJ, Pichard AD, Satler LF, Kent KM, et al. Mechanisms and results of balloon angioplasty for the treatment of in-stent restenosis . Am J Cardiol . 1996;78:618–622
  6. Alfonso F, Cequier A, Zueco J, Moris C, Suarez CP, Colman T, et al. Stenting the stent (initial results and long-term clinical and angiographic outcome of coronary stenting for patients with in-stent restenosis) . Am J Cardiol . 2000;85:327–332
  7. Adamian M, Colombo A, Briguori C, Nishida T, Marsico F, Di Mario C, et al. Cutting balloon angioplasty for the treatment of in-stent restenosis (a matched comparison with rotational atherectomy, additional stent implantation and balloon angioplasty) . J Am Coll Cardiol . 2001;38:672–679
  8. vom Dahl J, Dietz U, Haager PK, Silber S, Niccoli L, Buettner HJ, et al  Rotational atherectomy does not reduce recurrent in-stent restenosis (results of the Angioplasty versus Rotational atherectomy for Treatment of diffuse In-Stent restenosis Trial (ARTIST)) . Circulation . 2002;105:583–588
  9. Waksman R , Raizner AE , Yeung AC , Lansky AJ , Vandertie L . Use of localised intracoronary beta radiation in treatment of in-stent restenosis (the INHIBIT randomised controlled trial) . Lancet . 2002;359:551–557
  10. Radke PW , Kaiser A , Frost C , Sigwart U . Outcome after treatment of coronary in-stent restenosis (results from a systematic review using meta-analysis techniques) . Eur Heart J . 2003;24:266–273
  11. Waksman R, Ajani AE, White RL, Chan R, Bass B, Pichard AD, et al. Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis . Circulation . 2004;109:340–344
  12. Kastrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Pache J, et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis (a randomized controlled trial) . JAMA . 2005;293:165–171
  13. Airoldi F, Rogacka R, Briguori C, Chieffo A, Carlino M, Montorfano M, et al. Comparison of clinical and angiographic outcome of sirolimus-eluting stent implantation versus cutting balloon angioplasty for coronary in-stent restenosis . Am J Cardiol . 2004;94:1297–1300
  14. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al  Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents . JAMA . 2005;293:2126–2130
  15. Neumann FJ, Desmet W, Grube E, Brachmann J, Presbitero P, Rubartelli P, et al. Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement . Circulation . 2005;111:2107–2111
  16. Degertekin M, Lemos PA, Lee CH, Tanabe K, Sousa JE, Abizaid A, et al. Intravascular ultrasound evaluation after sirolimus eluting stent implantation for de novo and in-stent restenosis lesions . Eur Heart J . 2004;25:32–38
  17. Tanabe K, Serruys PW, Grube E, Smits PC, Selbach G, van der Giessen WJ, et al  TAXUS III trial (in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation) . Circulation . 2003;107:559–564
  18. Sousa JE, Costa MA, Abizaid A, Sousa AG, Feres F, Mattos LA, et al  Sirolimus-eluting stent for the treatment of in-stent restenosis (a quantitative coronary angiography and three-dimensional intravascular ultrasound study) . Circulation . 2003;107:24–27
  19. Degertekin M, Regar E, Tanabe K, Smits PC, van der Giessen WJ, Carlier SG, et al. Sirolimus-eluting stent for treatment of complex in-stent restenosis (the first clinical experience) . J Am Coll Cardiol . 2003;41:184–189
  20. Airoldi F, Di Mario C, Stankovic G, Briguori C, Bramucci E, Reimers B, et al. Effectiveness of treatment of in-stent restenosis with an 8-French compatible atherectomy catheter . Am J Cardiol . 2003;92:725–728
  21. Strauss BH, Umans VA, van Suylen RJ, de Feyter PJ, Marco J, Robertson GC, et al  Directional atherectomy for treatment of restenosis within coronary stents (clinical, angiographic and histologic results) . J Am Coll Cardiol . 1992;20:1465–1473
  22. Briguori C, Condorelli G, Airoldi F, Manganelli F, Violante A, Focaccio A, et al. Impact of microvascular complications on outcome after coronary stent implantations in patients with diabetes . J Am Coll Cardiol . 2005;45:464–466
  23. Abizaid A, Kornowski R, Mintz GS, Hong MK, Abizaid AS, Mehran R, et al. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation . J Am Coll Cardiol . 1998;32:584–589
  24. Abizaid A, Costa MA, Centemero M, Abizaid AS, Legrand VM, Limet RV, et al  Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients (insights from the Arterial Revascularization Therapy Study (ARTS) trial) . Circulation . 2001;104:533–538
  25. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery . N Engl J Med . 2003;349:1315–1323
  26. Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions . Circulation . 2003;108:788–794
  27. Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease . N Engl J Med . 2004;350:221–231
  28. Orlic D, Bonizzoni E, Stankovic G, Airoldi F, Chieffo A, Corvaja N, et al. Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation (immediate and mid-term results) . J Am Coll Cardiol . 2004;43:1154–1160
  29. Lemos PA, Hoye A, Goedhart D, Arampatzis CA, Saia F, van der Giessen WJ, et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients (an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study) . Circulation . 2004;109:1366–1370
  30. Hausleiter J, Kastrati A, Mehilli J, Vogeser M, Zohlnhofer D, Schuhlen H, et al. Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis (the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial) . Circulation . 2004;110:790–795

PII: S0002-9149(06)00038-5

doi: 10.1016/j.amjcard.2005.11.034

American Journal of Cardiology
Volume 97, Issue 8 , Pages 1182-1187 , 15 April 2006